Pfizer announces positive results from phase-III study in 20-valent Pneumococcal Conjugate Vaccine in infants in EU Read more
Pfizer announces positive top-line results from phase-III trial of pentavalent meningococcal vaccine candidate in adolescents Read more
Bharat Biotech seeks drug regulator’s nod for Incovacc’s phase-III study in five-18 age group Read more
ZeNix trial shows effectiveness of BPaL regimen for TB can be maintained with reduced dosing of Linezolid Read more